bupropion and ketamine

bupropion has been researched along with ketamine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's5 (62.50)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Abelaira, HM; Borba, LA; Botelho, MEM; de Moura, AB; Fileti, ME; Garbossa, L; Goldim, MP; Gonçalves, CL; Ignácio, ZM; Petronilho, F; Quevedo, J; Réus, GZ; Rosa, T; Veron, DC1
Kennedy, S; Lapointe, T; Leatham, Z; Leri, F; Melanson, B; Wolter, M1
Orsolini, L; Salvi, V; Volpe, U1
Cook, J; Halaris, A1
Chaki, S; Watanabe, M1

Reviews

3 review(s) available for bupropion and ketamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Craving and addictive potential of esketamine as side effects?
    Expert opinion on drug safety, 2022, Volume: 21, Issue:6

    Topics: Adult; Bupropion; Craving; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ketamine

2022
Antidepressants in the post-ketamine Era: Pharmacological approaches targeting the glutamatergic system.
    Neuropharmacology, 2023, Feb-01, Volume: 223

    Topics: Antidepressive Agents; Bupropion; Depression; Drug Discovery; Ketamine; United States

2023

Other Studies

5 other study(ies) available for bupropion and ketamine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.
    Pharmacological reports : PR, 2021, Volume: 73, Issue:2

    Topics: Animals; Antidepressive Agents; Bupropion; Combined Modality Therapy; Depressive Disorder, Major; Electroconvulsive Therapy; Fluoxetine; Ketamine; Male; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar

2021
Conditioned anti-immobility by ketamine: A comparison to escitalopram and bupropion.
    Experimental and clinical psychopharmacology, 2023, Volume: 31, Issue:2

    Topics: Animals; Antidepressive Agents; Bupropion; Escitalopram; Ketamine; Male; Rats; Rats, Sprague-Dawley

2023
Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression.
    Progress in neuro-psychopharmacology & biological psychiatry, 2022, 12-20, Volume: 119

    Topics: Bupropion; Depression; Depressive Disorder, Treatment-Resistant; Dopamine; Humans; Ketamine; N-Methylaspartate

2022